VRNS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Varonis to Proofpoint
Globe Newswire•21/10/2026•10:22 ET
0
Key Highlights
- ➤Varonis sale proposed at $49.75 per share in cash to Proofpoint
- ➤Sale price trails Varonis’s 52-week high of $63.80
- ➤Five Wall Street price targets ranged from $55.00 to $60.00
- ➤Wohl & Fruchter is investigating the transaction’s fairness for shareholders
Expert Statements
Joshua Fruchter, Founding partner of Wohl & Fruchter LLP
“We are investigating whether the Varonis Board of Directors acted in the best interests of Varonis shareholders in approving the sale”
Joshua Fruchter, Founding partner of Wohl & Fruchter LLP
“This includes whether the cash consideration agreed upon is fair to Varonis shareholders and whether all material information regarding the transaction has been fully disclosed.”
Joshua Fruchter, Founding partner of Wohl & Fruchter LLP
“We encourage Varonis shareholders to contact us if they have any concerns.”
MONSEY, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Varonis Systems, Inc. (NASDAQ: VRNS) (“Varonis”) to Proofpoint, Inc., a portfolio company of Thoma Bravo, for $49.75 per share in cash.
Notably, the $49.75 sale price is below Varonis’s 52-week high of $63.80, which potentially indicates an opportunistic purchase below fair value.
Get started
Create a free account to read the full story.